NASDAQ:CLYM | Profit Breakdown | Climb Bio, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$15.36M-$13.5M
2026-03-31-$15.21M-$13.72M
2025-12-31-$19.3M-$17.52M
2025-09-30-$14.89M-$12.89M
2025-06-30-$10.68M-$8.67M
2025-03-31-$23.02M-$20.78M
2024-12-31-$10.91M-$8.42M
2024-09-30-$11.73M-$8.9M
2024-06-30-$56.37M-$54.89M
2024-03-31-$3.01M-$1.7M
2023-12-31-$5.12M-$3.64M
2023-09-30-$5M-$3.97M
2023-06-30-$6.71M-$5.22M
2023-03-31-$23.44M-$22.29M
2022-12-31-$9.55M-$7.76M
2022-09-30-$8.75M-$9.68M
2022-06-30-$13.7M-$14.6M
2022-03-31-$13.13M-$13.2M
2021-12-31-$10.7M-$10.55M
2021-09-30-$9.38M-$9.62M
2021-06-30-$8.71M-$8.72M
2021-03-31-$6.88M-$18.6M
2020-12-31-$15.11M-$14.86M
2020-09-30-$2.26M-$2.26M
2020-06-30-$1.61M-$1.63M
2020-03-31-$1.92M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$67.88M-$59.85M
2024-12-31-$82.02M-$73.9M
2023-12-31-$40.28M-$35.12M
2022-12-31-$45.14M-$45.24M
2021-12-31-$35.67M-$47.48M
2020-12-31-$20.93M-$20.67M